Lab receives first NIH/NCI R37 Award

In 2025, the lab received funding from the NIH/NCI 1R37CA295527-01 to determine fatty acid metabolism-based mechanisms human B-ALL survival during CAR-T therapy and establish fatty acid uptake inhibition as a potential strategy to improve CAR-T efficacy, reflecting the public health relevance of this project.